Earn CME for related activities: hmpeducation.com/
In this presentation from the 'FLT3 Targets in AML: Evaluating Emerging Clinical Data and Implications on Current Practice’ symposium, Dr. Gail J. Roboz discusses the correct targets for patients with newly diagnosed acute myeloid leukemia (AML).
Негізгі бет Newly diagnosed AML: Hitting the right target
Пікірлер: 2